Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. (RKDA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rkda · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$6.00
+525.1% upside
Low
$6.00
Median: $6 · Last Close: $0.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RKDA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-07-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-06-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-08-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-01-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Arcadia Biosciences, Inc. (RKDA) stock. Of the recent 17 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover RKDA.
Analyst Recommendation Trends
RKDA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$11M
↑ 120.9% YoY
Revenue Next Year
$5M
↓ 52.3% YoY
EPS This Year
$-26.40
EPS Next Year
$-5.89
↓ 77.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast RKDA EPS of $-26.40 for the current fiscal year, based on estimates from 1 analysts. The RKDA revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RKDA stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RKDA price target is $6.00 (+525.1% upside), with an analyst consensus of Buy.
Arcadia Biosciences, Inc. trades on NASDAQ under the ticker RKDA. The RKDA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
RKDA forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month RKDA price target is $6.00, with a high forecast of $6.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +525.1% potential upside from the current price of $0.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.